US 7375181
Process for purifying glycopeptide phosphonate derivatives
granted A61PA61P31/04
Quick answer
US patent 7375181 (Process for purifying glycopeptide phosphonate derivatives) held by Theravance, Inc. expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P31/04